This company has been marked as potentially delisted and may not be actively trading. Myovant Sciences (MYOV) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock MYOV Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Myovant Sciences Stock Price HistoryJune 2, 2025 | investing.comVivek Ramaswamy's Net Worth: How Donald Trump's Key Aide Made His BillionsNovember 13, 2024 | msn.comBorn To Indian Immigrants, Now Part Of Trump's 'DOGE' Plan – How Vivek Ramaswamy Became A Billionaire By Shedding Unprofitable Pharma AssetsNovember 13, 2024 | msn.comGlobal Prostate Cancer Diagnostics Market to Observe Stunning Growth at a CAGR of ~12% by 2030 | DelveInsightSeptember 25, 2024 | finance.yahoo.comThe Scientific Establishment Is Turning 'Science' Into a Dogmatic Tool of Oppression | OpinionSeptember 11, 2024 | newsweek.comNInovio Pharmaceuticals, Inc. (NASDAQ:INO) Q2 2024 Earnings Call TranscriptAugust 9, 2024 | msn.comGynecology Collaboration, R&D, and Licensing Deals Trends Report 2024May 7, 2024 | finance.yahoo.comWorld Metastatic Prostate Cancer Drug Landscape Research Report 2024: Comprehensive Insights about 90+ Companies and 110+ Pipeline DrugsApril 18, 2024 | uk.finance.yahoo.com2024 Could Be Women’s Health’s Long-Awaited, Much-Needed Standout YearJanuary 15, 2024 | forbes.comGlobal $67B+ Women's Health Market Landscape 2024-2030: Analysis by Age, Application and RegionJanuary 11, 2024 | finance.yahoo.comReAlta Life Sciences Strengthens Board of Directors with Appointment of Three Accomplished Biotechnology ExecutivesJanuary 3, 2024 | finance.yahoo.comVivek Ramaswamy wins legal battle over bid to force him to give evidence in multi-million dollar court case after GOP long-shot candidate claimed he was too busy campaigning to ...December 28, 2023 | dailymail.co.ukMetastatic Castration-Sensitive Prostate Cancer Market to Skyrocket at Astounding 22% CAGR During the Study Period (2019-2032), assesses DelveInsightDecember 8, 2023 | finance.yahoo.comNCCN Announces Funding for Advanced Prostate Cancer Research ProjectsNovember 21, 2023 | markets.businessinsider.comMyovant Sciences, Ltd. (MYOV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsOctober 22, 2023 | barrons.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Myovant Sciences, Ltd. - MYOVSeptember 26, 2023 | benzinga.com4D Molecular Therapeutics Appoints Uneek Mehra Finance & Business ChiefSeptember 12, 2023 | marketwatch.comVivek Ramaswamy claims he is too busy campaigning to give evidenceAugust 29, 2023 | msn.com2024 Presidential candidate Vivek Ramaswamy trying to duck legal battle over his biotech empireAugust 29, 2023 | msn.comEXCLUSIVE: Vivek Ramaswamy claims he is too busy campaigning for President to give evidence in multi-million dollar court caseAugust 28, 2023 | msn.comVivek Ramaswamy cites campaign to duck deposition in buyout suitAugust 28, 2023 | msn.comBill Ackman Tells Vivek Ramaswamy How To Run For PresidentAugust 24, 2023 | msn.comUterine Fibroids Treatment Global Market Report 2023August 24, 2023 | finance.yahoo.comPresidential Hopeful Ramaswamy Predicts US Recession In 2024August 21, 2023 | benzinga.comHormone Therapy Global Market Report 2023July 4, 2023 | uk.finance.yahoo.comHealth in Her HUE to Host Discussion Around Fibroids Awareness and Launch the Fibroids-focused Care Squad Program during Fibroid Awareness MonthJune 26, 2023 | finance.yahoo.comAntibacterial Drugs Market to Reach US$ 62 Billion by 2031 | Fact.MR ReportJune 22, 2023 | benzinga.comWomen's Health Market to Reach $63.02 Billion by 2030: Grand View Research, Inc.May 18, 2023 | finance.yahoo.comMyovant Sciences and Evidation Announce Survey Results of Unseen Burdens at Work and School of Individuals with Endometriosis and/or Uterine FibroidsMay 17, 2023 | finance.yahoo.comEndometriosis Treatment Drugs Market Top Competitors and Prediction Till 2030May 16, 2023 | marketwatch.comMetastatic Prostate Cancer Treatment Market Size: Growth Dynamics from 2023 to 2031May 10, 2023 | marketwatch.comMenstrual Cramps Treatment Market worth growing 4.0% at a CAGR by 2027May 8, 2023 | marketwatch.comGlobal "Metastatic Prostate Cancer Treatment Market" Growth and Outlook till 2023-2030May 8, 2023 | marketwatch.com8-K: Day One Biopharmaceuticals, Inc.May 2, 2023 | marketwatch.comProstate Cancer Treatment Market Business Expands Quickly and Will Occupy Over USD 12,152 Million by 2030April 27, 2023 | marketwatch.comEndometriosis Market Growth by 2031April 26, 2023 | marketwatch.comMyovant Sciences won 3 drug approvals and got bought out. Now it's cutting nearly 100 jobs.April 25, 2023 | bizjournals.comLeading National Prostate Cancer Nonprofit Announces Return of Annual Run/Walk SeriesApril 25, 2023 | finance.yahoo.comMyovant Sciences (NYSE:MYOV) Receives New Coverage from Analysts at StockNews.comApril 11, 2023 | marketbeat.comSumitomo Pharma Subsidiary Companies in the U.S., Including Sumitovant and its Wholly Owned Subsidiaries, to Combine and Form Sumitomo Pharma AmericaApril 3, 2023 | finance.yahoo.comMyovant Sciences (NYSE:MYOV) Now Covered by Analysts at StockNews.comApril 3, 2023 | marketbeat.comEndometriosis Global Market Report 2022: Rise in Demand for Novel Drugs and Hormonal Therapies Bolsters SectorMarch 29, 2023 | finance.yahoo.comEndometriosis Treatment Drugs Market Growth By 2031March 26, 2023 | marketwatch.comMyovant Sciences (NYSE:MYOV) Coverage Initiated at StockNews.comMarch 26, 2023 | marketbeat.comHennion & Walsh Asset Management Inc. Sells 141,504 Shares of Myovant Sciences Ltd. (NYSE:MYOV)March 21, 2023 | marketbeat.comMyovant Sciences (NYSE:MYOV) Now Covered by StockNews.comMarch 18, 2023 | marketbeat.comMyovant Sciences Ltd. (NYSE:MYOV) Major Shareholder Chemical Co. Ltd. Sumitomo Acquires 51,599,200 SharesMarch 10, 2023 | marketbeat.comGlobal GnRH Receptor Antagonists Market research Report with Analysis 2023 To 2028March 10, 2023 | marketwatch.comMyovant Sciences (NYSE:MYOV) HeadlineTrading was temporarily halted for "MYOV" at 08:03 AM with a stated reason of "Merger Effective."...March 10, 2023 | marketbeat.comAs a two-time CEO, Lynn Seely is putting more cracks in the glass ceilingMarch 3, 2023 | bizjournals.com Get Myovant Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MYOV and its competitors with MarketBeat's FREE daily newsletter. Email Address MYOV Media Mentions By Week MYOV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MYOV News Sentiment▼0.000.57▲Average Medical News Sentiment MYOV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MYOV Articles This Week▼00▲MYOV Articles Average Week Get Myovant Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MYOV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MOR News CALT News ZYME News CMRX News MBX News CKPT News AVTE News TSVT News SLRN News CYBN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:MYOV) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Myovant Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Myovant Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
